QAQuratul Ain

Quratul Ain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Quratul Ain has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and clinical characteristics of probable familial chylomicronaemia syndrome at a tertiary care center in Pakistan: Insights from a hospital-based screening study

    by Quratul Ain, Naim-Ul Huda, Madeeha Khan, Amjad Nawaz, Zoraiz Ali, Jaka Sikonja, Mohammad Iqbal Khan, Muhammad Ajmal, Fouzia Sadiq, Urh Groselj

  • Open Access

    Early mortality in children with homozygous familial hypercholesterolemia: Case reports of deaths at ages 5 and 7 and a systematic review of global evidence

    by Madeeha Khan, Quratul Ain, Jaka Sikonja, Barbara Cugalj Kern, Hijab Batool, Sabeen Abid Khan, Muhammad Qasim Hayat, Mohammad Iqbal Khan, Urh Groselj, Fouzia Sadiq


  • Trends and prevalence of severe hypertriglyceridemia in Pakistan: A 5-year analysis (2019-2023)

    by Quratul Ain, Madeeha Khan, Amjad Nawaz, Hijab Batool, Mohammad Iqbal Khan, Muhammad Ajmal, Fouzia Sadiq


  • Open Access

    Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region

    by Madeeha Khan, Quratul Ain, Jaka Sikonja, Hijab Batool, Muhammad Qasim Hayat, Mohammad Iqbal Khan, Urh Groselj, Fouzia Sadiq

    Background: Familial hypercholesterolemia (FH) is an inherited disorder that causes elevated LDL-C levels leading to premature cardiovascular disease but remains underdiagnosed. This study aims to determine the prevalence of FH in Pakistan using data from multiple laboratory networks and compare it with other counties of the region. Methods: The study analyzed lipid profile data from two large laboratory networks in Pakistan, applying Make Early Diagnosis to Prevent Early Death (MEDPED) LDL-C criteria for the general population to identify FH cases. A pooled prevalence estimate of prevalence of FH in Pakistan was calculated by combining the data of studies reporting prevalence in Pakistan. A systematic review was conducted to assess FH prevalence in South and Southeast Asian countries. Results: Analysis of 545,087 individuals (Median age 45 years, 58.2% males) identified 2,911 FH cases [0.55%, 95% confidence interval (CI): 0.53–0.57%), equivalent to a prevalence of 1:182. Pooled analysis with a previous Pakistani study, totaling 1,533,393 subjects, estimated the overall FH prevalence in Pakistan at 1:273 (95% CI: 0.21–0.64%). Prevalence decreased with age, being highest in the <20 years group (1:29), while no gender differences were observed. A systematic review of South and Southeast Asian countries revealed limited data, with FH prevalence estimates missing for majority of the countries of the region. Conclusion: This study provides an updated estimate of FH prevalence in Pakistan and highlights the scarcity of data in South and Southeast Asia.


  • Open Access

    Gender Disparity in Lipid Testing Among Over 0.5 Million Adults from Pakistan: Females are Tested Much Later Despite Higher LDL-Cholesterol Levels

    by Amjad Nawaz, Madeeha Khan, Quratul Ain, Muhammad Amjad, Jaka Sikonja, Hijab Batool, Mohammad Iqbal Khan, Urh Groselj, Fouzia Sadiq

    Background and aims: Dyslipidemia is the major risk factor for atherosclerotic cardiovascular disease (ASCVD); therefore, its early diagnosis and treatment is necessary. While previous studies in Pakistan focused on general lipid profiles, investigations into gender disparities in lipid testing remain scarce. Therefore, the present study aims to explore the gender disparity in lipid testing and lipid levels among the adult Pakistani population. Methods: The lipid profile data was obtained from a tertiary care hospital and a diagnostic laboratory with centers across Pakistan. Dyslipidemia was defined based on the criteria provided by the National Cholesterol Education Program (NCEP) guidelines. Gender-based differences in lipid levels were analysed by copula decomposition, breaking down dyslipidemia differences into composition and structure effects. Results: A total of 577,489 adults were included in this study. The highest number of tests (n = 86,709, 14.6%) were conducted in individuals aged between 50 to 54 years. Greater number of males (n = 203,415, 64.3%) were tested before the age of 50 years compared to females (n = 113,030, 35.7%). Conversely, after the age of 50 years, number of tests increased notably among females (n = 137,541, 52.7%) compared to males (n = 123,503, 47.3%; p < 0.001). For all comparisons, significant differences were observed for low density lipoprotein cholesterol (LDL-C), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) levels between males and females (p < 0.001), where average levels of LDL-C, TC and HDL-C were higher in females while average TG levels were higher in males. Conclusion: This study highlights the gender disparity in lipid testing in Pakistan, where females undergo lipid testing later in life, despite higher lipid levels compared to males.


  • Open Access

    Frequency of lipoprotein(a) testing and its levels in Pakistani population

    by Hijab Batool, Madeeha Khan, Quratul Ain, Omar R. Chughtai, Muhammad D. Khan, Mohammad I. Khan, Fouzia Sadiq

    Background Lipoprotein(a) [Lp(a)] is a highly atherogenic particle identified as an independent risk factor for the development of atherosclerotic cardiovascular disease (ASCVD). This study aimed to investigate the frequency of Lp(a) testing and incidence of elevated Lp(a) in the Pakistani population. Methods For this observational study, Lp(a) and lipid profile data from five years (June 2015 to October 2020) were acquired from the electronic patient records of a diagnostic laboratory (Chughtai Laboratories, Lahore). The association of age, total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein cholesterol (LDL-C), non-HDL, and triglyceride (TG) levels with two thresholds for Lp(a), that is, Results For five years, 1060 tests were conducted, averaging 212 tests per year. Of these tests, 37.2% showed Lp(a) levels above 30 mg/dL. There were no significant differences observed in the results between males and females. However, younger individuals displayed significantly higher Lp(a) levels. Additionally, there was only a weak correlation between Lp(a) levels and other lipid variables. Conclusion Despite being recognized as a risk factor for ASCVD in the Pakistani population, only a small proportion of the large population had their Lp(a) tested. Moreover, a significant proportion of the population lies above the threshold.

  • Open Access

    Side effects of COVID-19 vaccination in Pakistani population: A cross sectional study

    by Quratul Ain, Madeeha Khan, Aleena Afrah, Zainab Akmal, Sadia Javed, Amjad Nawaz, Mohammad Iqbal Khan, Fouzia Sadiq

    _OBJECTIVES:_ Data from clinical trials around the world show that the COVID-19 vaccines are effective in terms of reducing hospitalizations need for respiratory support and deaths. However, to assess common or uncommon adverse events of the COVID-19 vaccines, data from real world experiences need to be evaluated to resolve the speculations associated with the vaccines. _MATERIALS AND METHODS:_ A questionnaire based on demographic details, vaccination details, side effects experienced, the duration of side effects and COVID-19 status was administered to study participants during this cross-sectional study. _RESULTS AND DISCUSSION:_ A total of 1162 responses were collected from fully vaccinated individuals, where Sinovac was the highly administered vaccine (40%). Most of the vaccinated participants (94%) did not contract SARS-CoV-2 infection following vaccination; however, the rate of hospitalization (4.2%) and development of extreme complications (1.4%) was lower in those who contracted the disease after vaccination compared to those who contracted COVID-19 before being fully vaccinated (7.1%). The most frequent side effects of vaccination reported were moderate pain at the site of injection administration, muscle pain, headache, fever, fatigue, swelling, redness or pain at the site of injection, nausea and joint pain. Only 2% of the participants encountered extreme daily routine difficulties while most of the side effects resolved within one week (30%). _CONCLUSION:_ The present study reports mild post vaccination side effects and low incidence of SARS-CoV-2 following COVID-19 vaccination. These results may help in improving the public perception and confidence towards COVID-19 vaccination in the Pakistani population.

  • Open Access

    Analysing the psychosocial and health impacts of Long COVID in Pakistan: A cross sectional study

    by Madeeha Khan, Sadaf Majeed, Qura Tul Ain, Amjad Nawaz, Khadija Awais Sumra, Vilma Lammi, Faizan Nihal, Aleena Afrah, Ejaz Ahmed Khan, Mohammad Iqbal Khan, et al.

    Long COVID corresponds to the occurrence of symptoms beyond twelve weeks after the onset of acute COVID-19 illness. The study aimed to analyze impacts of long COVID on the general health and psychosocial well-being of the Pakistani population. This cross-sectional study aimed to analyse the impacts of long COVID on general health and psychosocial well-being. For this study, the participants were interviewed, and their responses were recorded on a questionnaire capturing information on demographics, COVID-19 status, duration of symptoms and long COVID symptoms. The psychological impacts of the pandemic were assessed using scales like Short Mood and feeling questionnaire (sMFQ), Warwick-Edinburgh Mental Well-being Scale (WEMWBS), Generalized Anxiety Disorder Assessment (GAD-7) and Perceived Stress Scale (PSS). Regression analysis was conducted to analyse the predictors of long COVID. A total of 300 participants were interviewed, of which 155 (52%) had COVID-19 illness. Of these 54 (35%) had persistent symptoms for a period of more than 12 weeks classified as long COVID. Muscle problems and fatigue were the most frequent (14.7%) symptoms encountered, followed by breathing problems (12.6%) and cognitive issues (12.6%). Symptoms such as decrease in appetite and confusion or disorientation during the initial phase of the infection were associated with long COVID. Majority of the participants (83.3%) had moderate level of perceived stress while moderate to severe levels of stress was observed in 17.3% of the individuals. Moreover, a high level positive mental wellbeing was also observed.